<乌鸦传媒>Reassurance on Steroid Shots for Knee OA Study counters fears that injections worsen underlying pathology Mar 17, 2022
<乌鸦传媒>Ankylosing Spondylitis: Another Step Toward Individualized Therapy Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
<乌鸦传媒>Hopes Dashed for Novel Osteoarthritis Treatment Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
<乌鸦传媒>Dyspnea in Woman With RA Reveals a Diaphragmatic Lipoma MRI can help differentiate these benign soft-tissue masses from more aggressive liposarcomas Feb 22, 2022
<乌鸦传媒>Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
<乌鸦传媒>Mystery: Why Would Hand OA Be Less Severe in Black People? Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
<乌鸦传媒>Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<乌鸦传媒>Muddled Picture for Antidepressant as Osteoarthritis Pain Reliever Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
<乌鸦传媒>Success for Upadacitinib in PsA, Despite Concerns JAK inhibitor nabs new indication after FDA called for boxed warnings on the class Dec 28, 2021
<乌鸦传媒>Hydroxychloroquine Linked to Less Heart Risk in RA, Lupus Current use of the antimalarial especially was particularly associated with less thrombosis Dec 28, 2021
<乌鸦传媒>Another Trial, Another PRP Flop in Osteoarthritis Fails to outperform saline in randomized trial Nov 23, 2021
<乌鸦传媒>Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<乌鸦传媒>Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
<乌鸦传媒>Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
<乌鸦传媒>Guselkumab Response Durable in Psoriatic Arthritis Skin and joint improvements persisted through 2 years of follow-up Nov 08, 2021
<乌鸦传媒>Early Biologics Better in Juvenile Idiopathic Arthritis After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
<乌鸦传媒>Brepocitinib Shows Promise in Phase II Trial for PsA Oral tyrosine kinase 2/JAK-1 inhibitor improved both joint and skin manifestations Nov 07, 2021
<乌鸦传媒>Targeting IL-23 Succeeds in Psoriatic Arthritis Patients had active, longstanding disease and inadequate responses to other agents Nov 07, 2021
<乌鸦传媒>Can Abatacept Reverse Early Rheumatoid Arthritis? At-risk patients showed improvements in inflammation -- and also delays in disease onset Nov 06, 2021
<乌鸦传媒>No Love for PRP in Ankle Osteoarthritis Trial Dutch researchers throw cold water on popular therapy Oct 26, 2021
<乌鸦传媒>How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<乌鸦传媒>First Interchangeable Humira Biosimilar Approved Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<乌鸦传媒>In RA, Little Risk for Recurrent Cancer With Biologic Treatment Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<乌鸦传媒>Statins Not Linked With Rheumatoid Arthritis, Large Study Finds Risks attenuated after adjustment for lipid levels Sep 22, 2021
<乌鸦传媒>IBD and Pediatric Arthritis: Exploring the Link Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
<乌鸦传媒>Lymphoma in RA: Disease Activity Matters Strongest risk factors were baseline disease activity scores and bone erosions Sep 08, 2021
<乌鸦传媒>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<乌鸦传媒>What Factors Predict RA in First-Degree Relatives? Study may offer insight into preclinical phase to identify factors that predict progression Aug 12, 2021
<乌鸦传媒>New-Onset IBD and IL-17 Inhibitors: What Is the Risk? Underlying inflammatory disease severity should be taken into account Jul 21, 2021
<乌鸦传媒>CV Risk in PsA: Do Drugs Matter? Study weighs in on heart safety of TNF inhibitors versus other biologics Jul 19, 2021
<乌鸦传媒>Effective Treatments for Hand Osteoarthritis: The Search Goes On Hydroxychloroquine not effective as disease-modifying drug for erosive hand OA, trial confirmed Jul 08, 2021
<乌鸦传媒>Rinvoq Shows Promise in Spine Disease 1-year results in ankylosing spondylitis demonstrate efficacy for JAK inhibitor upadacitinib Jul 02, 2021
<乌鸦传媒>Target TNF or IL-12/23 in Psoriatic Arthritis? Both TNF inhibitors and ustekinumab were effective in real-world use Jun 30, 2021
<乌鸦传媒>New ACR Rheumatoid Arthritis Guideline: Emphasis on Methotrexate Many RA patients succeed with optimized use of the DMARD before adding another medication Jun 28, 2021
<乌鸦传媒>Pain Persists in RA, Even Without Inflammation At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
<乌鸦传媒>Osteoarthritis: A Link With Parkinson's? Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
<乌鸦传媒>Secukinumab Shows Promise for Kids With Arthritis More than 90% responded at week 12, study showed Jun 07, 2021
<乌鸦传媒>Rituximab a Hazard in RA Patients With COVID Poor outcomes were fourfold higher among rituximab users than for those on TNF inhibitors Jun 03, 2021
<乌鸦传媒>Methotrexate Impairs COVID Vax Response Can extra vaccine doses or discontinuing drug benefit patients with immune-mediated diseases? May 25, 2021
